Skip to main content
Triangle logo TriangleGet started

Radiomics on MRI (NCT06444269)

Precision Medicine in Action: Phase II Trial of Response Adaptive Ablative Pre-operative SPBI (RAPS) and Non-operative Sentinel Lymph Node Biopsy in Patients With Early-stage ER+ Breast Cancer: RAPS Trial: a one-minute explainerNCT064442691 min

Radiomics on MRI trial for Breast Cancer (NCT06444269). This is a short film with English narration. The transcript is on this page, and the written brief is separate.

What the film says

Read the transcript

This trial is for adult women with untreated, hormone-receptor-positive, HER2-negative breast cancer, without involved nodes and spanning no more than three centimeters.

The idea: targeted radiation treats the breast tumor before surgery. Patients receive thirty gray once. Those without a complete imaging or biopsy response at nine months receive eight gray more. Surgery follows at ten to fifteen months, depending on response. Imaging and biopsies track response; this study does not omit surgery.

This phase 2 study plans 53 patients. Asal Rahimi leads at UT Southwestern, Dallas, the sole recruiting US site.

Public record; not medical advice.

Read the full brief →

Already in a trial?

It turns into a project to manage: visits, scans, labs, side effects and paperwork. Triangle keeps it organized in one place for you or for whoever's helping.

Organize my trial

7-day free trial, then $9 a month. Cancel anytime.